valproic acid and fingolimod hydrochloride

valproic acid has been researched along with fingolimod hydrochloride in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (80.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Chabwine, JN; Démonet, JF; du Pasquier, RA; Hirt, L; Kuntzer, T; Michel, P; Rossetti, AR; Schluep, M; Vingerhoets, FG1
Anderson, G; Rodriguez, M1
Perez, RG; Segura-Ulate, I; Vargas-Medrano, J; Yang, B1
Ghasemi-Kasman, M; Hashemian, M; Parsian, H; Sadeghi, F1
Doello, K; Mesas, C; Ortiz, R; Perazzoli, G; Quiñonero, F; Rama, AR; Vélez, C1

Reviews

1 review(s) available for valproic acid and fingolimod hydrochloride

ArticleYear
Multiple sclerosis: the role of melatonin and N-acetylserotonin.
    Multiple sclerosis and related disorders, 2015, Volume: 4, Issue:2

    Topics: Fingolimod Hydrochloride; Glatiramer Acetate; Humans; Immunologic Factors; Immunosuppressive Agents; Interferon-beta; Lithium Compounds; Melatonin; Multiple Sclerosis; Nootropic Agents; Serotonin; Valproic Acid

2015

Other Studies

4 other study(ies) available for valproic acid and fingolimod hydrochloride

ArticleYear
[Neurology].
    Revue medicale suisse, 2012, Jan-11, Volume: 8, Issue:323

    Topics: Antibodies, Monoclonal; Anticonvulsants; Atrial Fibrillation; Carbamates; Chronic Disease; Deep Brain Stimulation; Dopamine Agonists; Epilepsy; Fingolimod Hydrochloride; Genetic Therapy; Humans; Immunosuppressive Agents; Ischemic Attack, Transient; Multiple Sclerosis; Muscular Diseases; Neurology; Parkinson Disease; Phenylenediamines; Polyneuropathies; Propylene Glycols; Sphingosine; Stroke; Treatment Outcome; Valproic Acid

2012
FTY720 (Fingolimod) reverses α-synuclein-induced downregulation of brain-derived neurotrophic factor mRNA in OLN-93 oligodendroglial cells.
    Neuropharmacology, 2017, 05-01, Volume: 117

    Topics: Acetylation; alpha-Synuclein; Animals; beta-Synuclein; Brain-Derived Neurotrophic Factor; Cells, Cultured; Down-Regulation; Fingolimod Hydrochloride; Histones; Humans; Mutation; Neuroglia; Neurons; Oligodendroglia; Rats; Valproic Acid

2017
Fingolimod (FTY720) improves the functional recovery and myelin preservation of the optic pathway in focal demyelination model of rat optic chiasm.
    Brain research bulletin, 2019, Volume: 153

    Topics: Animals; Demyelinating Diseases; Disease Models, Animal; Fingolimod Hydrochloride; Histone Deacetylase 1; Lysophosphatidylcholines; Male; Multiple Sclerosis; Myelin Sheath; Oligodendroglia; Optic Chiasm; Rats; Rats, Wistar; Recovery of Function; Remyelination; Sphingosine-1-Phosphate Receptors; Valproic Acid

2019
Antitumor Effect of Traditional Drugs for Neurological Disorders: Preliminary Studies in Neural Tumor Cell Lines.
    Neurotoxicity research, 2022, Volume: 40, Issue:6

    Topics: Adult; Apoptosis; Biperiden; Brain Neoplasms; Cell Line, Tumor; Dextromethorphan; Fingolimod Hydrochloride; Glioblastoma; Haloperidol; Humans; Levetiracetam; Methotrimeprazine; Valproic Acid

2022